Search keyWord :

PayerMax Makes a Strong Debut at G-STAR Korea, Championing Seamless Global Payment Solutions for the Gaming Industry

SEOUL,South Korea,Nov. 18,2024-- PayerMax,a leading global fintech company,made its inaugural appearance at G-STAR Korea,one of the world\'s most prestigious gaming events. This milestone marks a sig

Boehringer Ingelheim Commits to Veeva Vault CRM

Top biopharma company selects the next generation of CRM for life sciencesas its commercial foundation for future expansion and launches

Konjac Shuang Nutritional Value Examined from the Scientific Perspective

SHANGHAI,Nov. 15,2024--Recently,the Konjac Shuang snack from famous Chinese mainland snack brand Weilong came into controversy for its "excessive sodium content" and "unknown ingredient

SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors

TEL AVIV,Israel,Nov. 18,2024--SoniVie Ltd.,a medical device company developing a proprietary renal denervation system to treat hypertension,announced today the appointment of Raymond W. Cohen to serve

Xinhua Silk Road: Jing'an District of China's Shanghai shines at import expo

BEIJING,Nov. 18,2024-- During the recently-concluded seventh China International Import Expo (CIIE),Jing\'an District of China\'s Shanghai has held a series of investment promotion activities in an at

Viettel Cyber Security Launches Free Cyber Threat Check Service in the Philippines--70% of Companies at the 21st ITIP National Conference 2024 Face Cyber Threat Risks

MANILA,Philippines,Nov. 18,2024-- In just the first half of 2024,Viettel Threat Intelligence uncovered over 315,000 compromised credentials,17,456 phishing attacks,and numerous vulnerabilities impacti

Visier Finds Singapore Organisations Need More Resources, Quality Data and Advanced Analytics to Address Growing Workforce Challenges

New research highlights key workforce challenges of organisations in Singapore with the vast majority struggling to hire and retain employees

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

Single dose of RN0191 achieved up to 95% individual maximum and 87% mean maximum PCSK9 reduction,and up to 74% individual maximum and 56% mean maximalLDL-C lowering

Citigroup's "Citigroup Jyoti Growth Scheme" Gains Government Support and Strong Investor Response

NetEase Announces Third Quarter 2024 Unaudited Financial Results

HANGZHOU,China,Nov. 14,2024-- NetEase,Inc. (NASDAQ: NTES and HKEX: 9999,"NetEase" or the "Company"),a leading internet and game services provider,today announced its unaudited fina